Alafosfalin

Class: Phosphonodipeptide

Spectrum of activity:	Gram-negative
Propensity to select resistant mutants:	Yes
Institute where first reported:	Roche Products Limitted
Year first mentioned:	1979
Highest developmental phase:	Preclinical
Development status:	Inactive
Reason Dropped:	Therapuetic usefulness limitted by selection of resistant mutants

Chemical structure(s):
Canonical SMILES:	CC(C(=O)NC(C)P(=O)(O)O)N
Isomeric SMILES:	CC(C(=O)NC(C)P(=O)(O)O)N
InChI:	InChI=1S/C5H13N2O4P/c1-3(6)5(8)7-4(2)12(9,10)11/h3-4H,6H2,1-2H3,(H,7,8)(H2,9,10,11)
InChI Key:	BHAYDBSYOBONRV-UHFFFAOYSA-N
Structure link:	https://pubchem.ncbi.nlm.nih.gov/compound/71957

External links:
Guide to Pharmacology:	alafosfalin
Citation:	https://www.ncbi.nlm.nih.gov/pubmed/116591